FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

21000172104: Belgian French language reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 15-Mar 2018. Module: Belgian module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
31000172117 Belgian French language reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) Belgian module (core metadata concept)
41000172112 Belgian French language reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Belgian module (core metadata concept)
80741000172111 fichier de référence français belge fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Belgian module (core metadata concept)
80721000172119 Belgisch-Frans referentiebestand nl Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Belgian module (core metadata concept)


252126 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Belgian French language reference set (foundation metadata concept) Is a French [International Organization for Standardization 639-1 code fr] language reference set (foundation metadata concept) true Inferred relationship Some

Members acceptabilityId
CIVD (coagulation intravasculaire disséminée) causée par le venin de serpent Acceptable (foundation metadata concept)
CIVD (coagulation intravasculaire disséminée) due à un placenta abruptio Acceptable (foundation metadata concept)
CIVD - coagulation intravasculaire disséminée Acceptable (foundation metadata concept)
CLIS (carcinome lobulaire in situ) du sein droit Acceptable (foundation metadata concept)
CLIS (carcinome lobulaire in situ) du sein gauche Acceptable (foundation metadata concept)
CLL (chaine légère libre) lambda monoclonale présente Acceptable (foundation metadata concept)
CLN (céroïde-lipofuscinose neuronale) infantile Acceptable (foundation metadata concept)
CLN (céroïde-lipofuscinose neuronale) juvénile Acceptable (foundation metadata concept)
CLN infantile tardive Acceptable (foundation metadata concept)
CLN, variante épilepsie nordique Acceptable (foundation metadata concept)
CLWM - cystic leukoencephalopathy without megalencephaly Acceptable (foundation metadata concept)
CM (coma myxœdémateux) iatrogène Acceptable (foundation metadata concept)
CMAMMA - combined malonic and methylmalonic aciduria Acceptable (foundation metadata concept)
CMC - chronic mucocutaneous candidiasis Acceptable (foundation metadata concept)
CMD (congenital muscular dystrophy) sans retard mental Acceptable (foundation metadata concept)
CMD1B - congenital muscular dystrophy type 1B Acceptable (foundation metadata concept)
CMD1C - congenital muscular dystrophy type 1C due to fukutin related protein gene mutation Acceptable (foundation metadata concept)
CMD1D - congenital muscular dystrophy type 1D large gene mutation Acceptable (foundation metadata concept)
CMDH - congenital muscular dystrophy with hyperlaxity Acceptable (foundation metadata concept)
CME (carcinome mucoépidermoïde) de la glande parotide Acceptable (foundation metadata concept)
CME (carcinome mucoépidermoïde) de la glande salivaire Acceptable (foundation metadata concept)
CMF - choroïdite multifocale Acceptable (foundation metadata concept)
CMRD - chylomicron retention disease Acceptable (foundation metadata concept)
CMT1A - Charcot-Marie-Tooth disease type 1A Acceptable (foundation metadata concept)
CMT1B - Charcot-Marie-Tooth disease type 1B Acceptable (foundation metadata concept)
CMT1C - Charcot-Marie-Tooth disease type 1C Acceptable (foundation metadata concept)
CMT1D - Charcot-Marie-Tooth disease type 1D Acceptable (foundation metadata concept)
CMT1F - Charcot-Marie-Tooth disease type 1F Acceptable (foundation metadata concept)
CMT1X - Charcot-Marie-Tooth disease type 1, X-linked Acceptable (foundation metadata concept)
CMT2 (Charcot-Marie-Tooth disease type 2) associée à DNAJB2 (dnaJ heat shock protein family (Hsp40) member B2) Acceptable (foundation metadata concept)
CMT2A1 - Charcot-Marie-Tooth disease type 2A1 Acceptable (foundation metadata concept)
CMT2A2 - Charcot-Marie-Tooth disease type 2A2 Acceptable (foundation metadata concept)
CMT2B - Charcot-Marie-Tooth disease type 2B Acceptable (foundation metadata concept)
CMT2C - Charcot-Marie-Tooth disease type 2C Acceptable (foundation metadata concept)
CMT2D - Charcot-Marie-Tooth disease type 2D Acceptable (foundation metadata concept)
CMT2E - Charcot-Marie-Tooth disease type 2E Acceptable (foundation metadata concept)
CMT2F - Charcot-Marie-Tooth disease type 2F Acceptable (foundation metadata concept)
CMT2G - Charcot-Marie-Tooth disease type 2G Acceptable (foundation metadata concept)
CMT2I - Charcot-Marie-Tooth disease type 2I Acceptable (foundation metadata concept)
CMT2J - Charcot-Marie-Tooth disease type 2J Acceptable (foundation metadata concept)
CMT2K - Charcot-Marie-Tooth disease type 2K Acceptable (foundation metadata concept)
CMT2L - Charcot-Marie-Tooth disease type 2L Acceptable (foundation metadata concept)
CMT2M - Charcot-Marie-Tooth disease type 2M Acceptable (foundation metadata concept)
CMT2N - Charcot-Marie-Tooth disease type 2N Acceptable (foundation metadata concept)
CMT2Q - Charcot-Marie-Tooth disease type 2Q Acceptable (foundation metadata concept)
CMT2R - Charcot-Marie-Tooth disease type 2R Acceptable (foundation metadata concept)
CMT2U - Charcot-Marie-Tooth disease type 2U Acceptable (foundation metadata concept)
CMT3X - Charcot-Marie-Tooth disease type 3, X-linked Acceptable (foundation metadata concept)
CMT4A - Charcot-Marie-Tooth disease type 4A Acceptable (foundation metadata concept)
CMT4B1 - Charcot-Marie-Tooth disease type 4B1 Acceptable (foundation metadata concept)
CMT4B2 - Charcot-Marie-Tooth disease type 4B2 Acceptable (foundation metadata concept)
CMT4C - Charcot-Marie-Tooth disease type 4C Acceptable (foundation metadata concept)
CMT4D - Charcot-Marie-Tooth disease type 4D Acceptable (foundation metadata concept)
CMT4E - Charcot-Marie-Tooth disease type 4E Acceptable (foundation metadata concept)
CMT4F - Charcot-Marie-Tooth disease type 4F Acceptable (foundation metadata concept)
CMT4G - Charcot-Marie-Tooth disease type 4G Acceptable (foundation metadata concept)
CMT4H - Charcot-Marie-Tooth disease type 4H Acceptable (foundation metadata concept)
CMT4J - Charcot-Marie-Tooth disease type 4J Acceptable (foundation metadata concept)
CMT4X - Charcot-Marie-Tooth disease type 4, X-linked Acceptable (foundation metadata concept)
CMT5X - Charcot-Marie-Tooth disease type 5, X-linked Acceptable (foundation metadata concept)
CMT6X - Charcot-Marie-Tooth disease type 6, X-linked Acceptable (foundation metadata concept)
CMTDIA - Charcot-Marie-Tooth disease, dominant intermediate type A Acceptable (foundation metadata concept)
CMTDIB - Charcot-Marie-Tooth disease type B Acceptable (foundation metadata concept)
CMTDIC - Charcot-Marie-Tooth disease type C Acceptable (foundation metadata concept)
CMTDID - Charcot-Marie-Tooth disease type D Acceptable (foundation metadata concept)
CMTDIE - Charcot-Marie-Tooth disease type E Acceptable (foundation metadata concept)
CMTDIF - Charcot-Marie-Tooth disease type F Acceptable (foundation metadata concept)
CMTX2 - Charcot-Marie-Tooth disease type 2, X-linked Acceptable (foundation metadata concept)
CMUSE - cryptogenic multifocal ulcerous stenosing enteritis Acceptable (foundation metadata concept)
CNM4 - centronuclear myopathy type 4 Acceptable (foundation metadata concept)
CORS - cerebellooculorenal syndrome Acceptable (foundation metadata concept)
COVID-19 Preferred (foundation metadata concept)
COVID-19 - coronavirus disease 2019 Acceptable (foundation metadata concept)
COVID-19 aigüe Preferred (foundation metadata concept)
COVID-19 asymptomatique Acceptable (foundation metadata concept)
COVID-19 détecté Acceptable (foundation metadata concept)
COVID-19 exclue Preferred (foundation metadata concept)
COVID-19 mRNA vaccin (BNT162b2) de Pfizer-BioNTech Preferred (foundation metadata concept)
COVID-19 mRNA vaccin (mRNA-1273) de Moderna Preferred (foundation metadata concept)
COVID-19 non détecté Acceptable (foundation metadata concept)
COVID-19 post-aigüe Preferred (foundation metadata concept)
COVID-19 vaccin à vecteur viral (AZD1222 (ChAdOx1-S recombinant)) de AstraZeneca, Oxford Preferred (foundation metadata concept)
COVID-19 vaccin à vecteur viral (JNJ-78436735(Ad26.COV2-S recombinant)) de Johnson et Johnson, Janssens Preferred (foundation metadata concept)
COXPD11 - combined oxidative phosphorylation defect type 11 Acceptable (foundation metadata concept)
COXPD12 - combined oxidative phosphorylation defect type 12 Acceptable (foundation metadata concept)
COXPD13 - combined oxidative phosphorylation defect type 13 Acceptable (foundation metadata concept)
COXPD14 - combined oxidative phosphorylation defect type 14 Acceptable (foundation metadata concept)
COXPD15 - combined oxidative phosphorylation defect type 15 Acceptable (foundation metadata concept)
COXPD17 - combined oxidative phosphorylation defect type 17 Acceptable (foundation metadata concept)
COXPD2 - combined oxidative phosphorylation defect type 2 Acceptable (foundation metadata concept)
COXPD20 - combined oxidative phosphorylation defect type 20 Acceptable (foundation metadata concept)
COXPD21 - combined oxidative phosphorylation defect type 21 Acceptable (foundation metadata concept)
COXPD23 - combined oxidative phosphorylation defect type 23 Acceptable (foundation metadata concept)
COXPD25 - combined oxidative phosphorylation defect type 25 Acceptable (foundation metadata concept)
COXPD26 - combined oxidative phosphorylation defect type 26 Acceptable (foundation metadata concept)
COXPD27 - combined oxidative phosphorylation defect type 27 Acceptable (foundation metadata concept)
COXPD28 - combined oxidative phosphorylation defect type 28 Acceptable (foundation metadata concept)
COXPD29 - combined oxidative phosphorylation defect type 29 Acceptable (foundation metadata concept)
COXPD30 - combined oxidative phosphorylation defect type 30 Acceptable (foundation metadata concept)
COXPD4 - combined oxidative phosphorylation defect type 4 Acceptable (foundation metadata concept)
COXPD5 - combined oxidative phosphorylation defect type 5 Acceptable (foundation metadata concept)

Start Previous Page 32 of 2522 Next End


Reference Sets

Reference set descriptor

Back to Start